| 2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas |
Articolo in rivista |
Vai |
| 2023 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells |
Articolo in rivista |
Vai |
| 2022 |
Targeting epigenetic alterations in cancer stem cells |
Review essay (rassegna critica) |
Vai |
| 2022 |
Cancer cell targeting by CAR-T cells: A matter of stemness |
Review essay (rassegna critica) |
Vai |
| 2022 |
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy |
Review essay (rassegna critica) |
Vai |
| 2022 |
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development |
Articolo in rivista |
Vai |
| 2022 |
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy |
Review essay (rassegna critica) |
Vai |
| 2022 |
Dissecting the Mechanism of Action of Spiperone— A Candidate for Drug Repurposing for Colorectal Cancer |
Articolo in rivista |
Vai |
| 2022 |
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2022 |
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 |
Articolo in rivista |
Vai |
| 2021 |
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery |
Articolo in rivista |
Vai |
| 2021 |
FACS-based protocol to assess cytotoxicity and clonogenic potential of colorectal cancer stem cells using a Wnt/β-catenin signaling pathway reporter |
Articolo in rivista |
Vai |
| 2021 |
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells |
Articolo in rivista |
Vai |
| 2021 |
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin |
Articolo in rivista |
Vai |
| 2021 |
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment |
Review essay (rassegna critica) |
Vai |
| 2021 |
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy |
Articolo in rivista |
Vai |
| 2020 |
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis |
Articolo in rivista |
Vai |
| 2019 |
Cancer Stem Cells: From Birth to Death |
Capitolo o Saggio |
Vai |
| 2019 |
Meeting the Challenge of Targeting Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2018 |
MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state |
Articolo in rivista |
Vai |
| 2017 |
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition |
Articolo in rivista |
Vai |
| 2016 |
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b |
Articolo in rivista |
Vai |
| 2016 |
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis |
Articolo in rivista |
Vai |
| 2014 |
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis |
Articolo in rivista |
Vai |
| 2011 |
Diacylglycerol kinase α mediatses 17-β-estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell line through the G protein-coupled estrogen receptor GPR30 |
Articolo in rivista |
Vai |
| 2011 |
Colorectal cancer stem cells and cell death |
Review essay (rassegna critica) |
Vai |
| 2010 |
Negative regulation of diacylglycerol kinase mediates adenosine-dependent hepatocyte preconditioning |
Articolo in rivista |
Vai |
